Note: Ingredients listed on restricted chemical lists
EC/CAS
25013-16-5
Name of the chemical
tert.-Butylhydroxyanisole (BHA); tert-butyl-4-methoxyphenol
Concentration
N/A
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
302-79-4
Name of the chemical
Tretinoin (INN) (retinoic acid and its salts)
Concentration
N/A
EC/CAS
246-563-8
Name of the chemical
tert.-Butylhydroxyanisole (BHA); tert-butyl-4-methoxyphenol
Concentration
N/A
EC/CAS
204-881-4
Name of the chemical
Butylated Hydroxytoluene
Concentration
N/A
EC/CAS
206-129-0
Name of the chemical
Tretinoin (INN) (retinoic acid and its salts)
Concentration
N/A
General Information
Revision date
2018-04-30
Product name
SOLAGE TOPICAL SOLUTION
Product Synonyms
FORMULATION CODE: A52A * STIEFEL PRODUCT * 4-HYDROXYANISOLE AND TRETINOIN, FORMULATED PRODUCT
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
This product is highly flammable. See section 11 for additional information on health hazards.
